PVT-1 / PlusVitech - LARVOL DELTA

Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer (clinicaltrials.gov) - P2 | N=24 | Recruiting | Sponsor: PlusVitech S.L. | Trial completion date: Dec 2022 ➔ Dec 2025 | Trial primary completion date: Dec 2022 ➔ Dec 2025

Metastases • Trial completion date • Trial primary completion date • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • EGFR • ROS1